Events Archives - Page 23 of 287

TuesdayDec 10, 2019 7:00 pm

Amarantus Bioscience Holdings Inc. (AMBS) Starts Presentation at 12th Annual LD Micro Main Event

Amarantus Bioscience (OTC: AMBS) is a JLABS alumnus biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases. The company’s lead therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia, one of the most difficult problems facing patients with Parkinson’s disease. Eltoprazine is currently in a Phase 2b clinical trial with results from the study expected in 2016. Eltoprazine is also being evaluated for the treatment of adult attention deficit hyperactivity disorder (ADHD) and Alzheimer’s aggression. For more information, visit the company’s website at www.amarantus.com. About NetworkNewsWire NetworkNewsWire…

TuesdayDec 10, 2019 7:00 pm

GI Dynamics Inc. (GIDYL) Starts Presentation at 12th Annual LD Micro Main Event

GI Dynamics (OTC: GIDYL) (ASX: GID) is the developer of EndoBarrier®, an endoscopically delivered device therapy for the treatment of Type 2 diabetes and obesity. The company’s revolutionary EndoBarrier® is a testament to the GI Dynamics mission. EndoBarrier® first endoscopically delivered device therapy for the treatment of Type 2 diabetes and obesity. EndoBarrier® is aimed to bridge the gap between pharmaceuticals and surgery by providing an alternate treatment option to help reduce HbA1c and weight for individuals who are underserved by drugs and injections, but for whom surgery is not an option. EndoBarrier® is not approved for sale and is…

TuesdayDec 10, 2019 7:00 pm

Rafael Holdings Inc. (RFL) Starts Presentation at 12th Annual LD Micro Main Event

Rafael Holdings (NYSE: RFL) includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafael's real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and an office condominium in Israel. Rafael's pharmaceutical holdings include interests in two clinical-stage oncology companies - Rafael Pharmaceuticals and LipoMedix. Rafael Pharmaceuticals is developing therapies that exploit the metabolic differences between normal cells and cancer cells in both solid and liquid cancers. LipoMedix is developing liposomal prodrugs…

TuesdayDec 10, 2019 7:00 pm

Enthusiast Gaming Holdings Inc. (TSX.V: EGLX) Starts Presentation at 12th Annual LD Micro Main Event

Enthusiast Gaming (TSX.V: EGLX) (FSE: 2AV) is building the world’s largest network of communities for gamers and esports fans. The company’s business is comprised of three main pillars: media, events and esports. The media network generates over 30 billion ad requests and over 1 billion page views per month. Enthusiast’s esports division, Luminosity Gaming, is a global esports franchise that consists of seven professional esports teams under ownership and management, including the Vancouver Titans Overwatch team and the Seattle-based Call of Duty team. Collectively, the integrated ecosystem reaches over 200 million gaming enthusiasts on a monthly basis. For more information,…

TuesdayDec 10, 2019 6:40 pm

Milestone Scientific Inc. (MLSS) Starts Presentation at 12th Annual LD Micro Main Event

Milestone Scientific (NYSE: MLSS) is a medical device company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology® is the company’s technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and…

TuesdayDec 10, 2019 6:40 pm

Acerus Pharmaceuticals Corp. (TSX: ASP) (ASPCF) Starts Presentation at 12th Annual LD Micro Main Event

Acerus Pharmaceuticals (TSX: ASP) (OTCQB: ASPCF) is focused on the commercialization and development of innovative pharmaceutical products that improve the patient experience. Founded in 2008, Acerus has grown into a fully integrated, specialty pharmaceutical company with expertise in all stages of the pharmaceutical product life-cycle. The company is focused on men’s health (urology and andrology). The company’s foundational product is NATESTO®, a testosterone therapy based on patented nasal gel technology, approved in the United States, Canada and South Korea for the treatment of adult males diagnosed with hypogonadism. For more information, visit the company’s website at www.aceruspharma.com. About NetworkNewsWire NetworkNewsWire…

TuesdayDec 10, 2019 6:20 pm

Sigma Labs Inc. (NASDAQ: SGLB) Starts Presentation at 12th Annual LD Micro Main Event

Sigma Labs (NASDAQ: SGLB) is an emerging provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D® brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D for 3D advanced-manufacturing technologies. Sigma Labs’ advanced, computer-aided software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production, uniquely allowing errors to be corrected in real time. For more information, visit the company’s website at www.sigmalabsinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation…

TuesdayDec 10, 2019 6:20 pm

Medicenna Therapeutics Corp. (TSX: MDNA) (MDNAF) Starts Presentation at 12th Annual LD Micro Main Event

Medicenna Therapeutics (TSX: MDNA) (OTCQB: MDNAF) is a clinical-stage immunotherapy company focused on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs) for the treatment of a broad range of cancers. Supported by a US$14.1M non-dilutive grant from CPRIT (Cancer Prevention and Research Institute of Texas), Medicenna's lead IL4-EC, MDNA55, has completed enrolling patients in a Phase 2b clinical trial for rGBM, the most common and uniformly fatal form of brain cancer, at top-ranked brain cancer centers in the U.S. MDNA55 has been studied in…

TuesdayDec 10, 2019 6:20 pm

Perion Network Ltd. (NASDAQ: PERI) Starts Presentation at 12th Annual LD Micro Main Event

Perion Network (NASDAQ: PERI) delivers data-driven online advertising and search solutions to brands and publishers. The company’s high-impact advertising division, Undertone, helps brands capture consumer attention via beautiful creative and proprietary ad formats served across top-tier publishers. Perion’s search division, CodeFuel, enables developers to optimize search traffic and generate incremental revenue. The company’s social advertising platform, MakeMeReach, drives marketing campaigns and demand generation at scale across Facebook, Twitter, Instagram and Snapchat. Perion’s ‘owned and operated’ consumer apps division delivers powerful and engaging mobile and desktop apps direct to consumers. For more information, visit the company’s website at www.perion.com. About NetworkNewsWire…

TuesdayDec 10, 2019 6:20 pm

Dolphin Entertainment Inc. (NASDAQ: DLPN) Starts Presentation at 12th Annual LD Micro Main Event

Dolphin Entertainment (NASDAQ: DLPN) is an independent entertainment marketing and premium content development company. Through its subsidiaries, 42West and The Door, the company provides expert strategic marketing and publicity services to many of the top brands, both individual and corporate, in the entertainment and hospitality industries. Dolphin's recent acquisition of Viewpoint Creative adds full-service creative branding and production capabilities to the company’s marketing group. Dolphin's legacy content production business, founded by Emmy-nominated CEO Bill O'Dowd, has produced multiple feature films and award-winning digital series. For more information, visit the company’s website at www.dolphinentertainment.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Events

Amarantus Bioscience Holdings Inc. (AMBS) Starts Presentation at 12th Annual LD Micro Main Event

GI Dynamics Inc. (GIDYL) Starts Presentation at 12th Annual LD Micro Main Event

Rafael Holdings Inc. (RFL) Starts Presentation at 12th Annual LD Micro Main Event

Enthusiast Gaming Holdings Inc. (TSX.V: EGLX) Starts Presentation at 12th Annual LD Micro Main Event

Milestone Scientific Inc. (MLSS) Starts Presentation at 12th Annual LD Micro Main Event

Acerus Pharmaceuticals Corp. (TSX: ASP) (ASPCF) Starts Presentation at 12th Annual LD Micro Main Event

Sigma Labs Inc. (NASDAQ: SGLB) Starts Presentation at 12th Annual LD Micro Main Event

Medicenna Therapeutics Corp. (TSX: MDNA) (MDNAF) Starts Presentation at 12th Annual LD Micro Main Event

Perion Network Ltd. (NASDAQ: PERI) Starts Presentation at 12th Annual LD Micro Main Event

Dolphin Entertainment Inc. (NASDAQ: DLPN) Starts Presentation at 12th Annual LD Micro Main Event

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search